Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1 Research Letter

   

Authors:	Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Zinzani, P. L.; Collins, G. P.; Fanale, M.; Fenton, K.; Dong, C.; Miao, H.; Grigg, A. P.
Title:	Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
Keywords:	adolescent; adult; cancer chemotherapy; young adult; overall survival; cancer staging; follow up; letter; dacarbazine; progression free survival; vinblastine; hodgkin disease; infertility; pneumonia; immunotherapy; bleomycin; disease exacerbation; classical hodgkin lymphoma; phase 3 clinical trial (topic); brentuximab vedotin; humans; human
Journal Title:	Haematologica
Volume:	109
Issue:	3
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2024-03-01
Start Page:	982
End Page:	987
Language:	English
DOI:	10.3324/haematol.2023.283303
PUBMED:	37794803
PROVIDER:	scopus
PMCID:	PMC10905068
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85186743546&doi=10.3324%2fhaematol.2023.283303&partnerID=40&md5=49d7dc8846c5ec08624391a2dc70a4d7
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/214645